AgingResearch.NewsJoin free

Genital mycosis

Disease

1 paper2 findings

  • Humans1

Associations

2

DPP-4 inhibitors

downin humans1

1 study

  1. DPP-4 inhibitors lower the risk of genital mycosis in humans.

    “In the subgroup analysis the incidence of GM was found to be relatively lesser in those receiving the DPP4 inhibitors in addition to SGLT2 inhibitors.”

    Humansin patients receiving SGLT2 inhibitors3 months

    SAT-537 The Safety Profile of Sodium-Glucose Co-transporter 2 Inhibitors in Type 2 Diabetes Mellitus With Special Reference to Genital Mycosis

    ENDO 2025 abstract22 Oct 2025

More on DPP-4 inhibitors

SGLT2 inhibitors

upin humans1+2.3%

1 study

  1. SGLT2 inhibitors raise the risk of genital mycosis in humans (2.27%).

    “The most common adverse events were frequent urination (4.6%), UTIs (2.5%), GM (2.27%), joint and back pain (2.0%), and increased thirst (1.7%).”

    Humanspatients with type 2 diabetes mellitus3 monthsn = 750

    SAT-537 The Safety Profile of Sodium-Glucose Co-transporter 2 Inhibitors in Type 2 Diabetes Mellitus With Special Reference to Genital Mycosis

    ENDO 2025 abstract22 Oct 2025

More on SGLT2 inhibitors

Latest

Related